When the agenda was approved at the start of the Covid-19 vaccine manufacturers’ hearing on Monday 10 October, Kathleen Van Brempt (S&D, Belgian), Chair of the European Parliament’s special committee set up to learn the lessons of Covid-19, expressed her disappointment about Albert Bourla, CEO of Pfizer, cancelling his participation in the day’s hearing. Pfizer sent Janine Small, the company’s president of international developed markets, to speak in place of Mr Bourla.
Ms Van Brempt...